logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
MAP kinase p38 beta Inhibitors (IC50, Ki)
Structure
Compound Name
Standard Type
Standard Values (in nM)
4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazoleIC5012.0 [1], 78.0 [2], 430.0 [3], 500.0 [4]
4-(4-Fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)-1H-imidazoleIC509.8 [1], 100.0 [2]
N-[2-Methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamideIC501.5 [1], 2.0 [2]
DoramapimodIC507.0 [1], 10000.0 [2]
LosmapimodKi25.12 [1]

Rows per page:

1–5 of 100

References
This online resource may be cited as follows
MLA
"Quest Database™ MAP kinase p38 beta Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 4 Dec. 2025, https://www.aatbio.com/data-sets/map-kinase-p38-beta-inhibitors-ic50-ki.
APA
AAT Bioquest, Inc. (2025, December 4). Quest Database™ MAP kinase p38 beta Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/map-kinase-p38-beta-inhibitors-ic50-ki.
BibTeXEndNoteRefMan